University Hospitals of Morecambe Bay NHS Foundation Trust

Lancashire and South Cumbria, Cancer Alliance

Management of High Grade Dysplasia patients

Time period: 2015-19
Cancer Alliance National
Number of High Grade Dysplasia patients in audit 59 1448
Cancer Alliance National
Method of Diagnosis
– First diagnosis confirmed by second pathologist 57 96.5% 86.9%
Treatment planning
– HGD plan discussed at MDT 54 91.5% 87.9%
– Treatment plan for active treatment 45 75.9% 81.1%
First treatment
– Endoscopic therapy (such as endoscopic resection) 45 75.9% 73.8%
– Surveillance 10 16.7% 11.0%

Management of oesophago-gastric cancer patients

Time period: 2017-2019
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 146 20528
Case ascertainment for OG cancer (%) 85-100%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
26 18.8% 13.3%
– Patients with referral source reported as unknown 0 0.0% 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 145 99.3% 86.9%
Treatment planning
– Patients having a plan for curative treatment 47 32.2% 38.5%
– Patients having a plan for non-curative treatment 99 67.8% 61.5%
– Patients with non-curative plans having chemotherapy or radiotherapy 49 49.5% 48.2%

Download this data as a PDF